Clinical Trials Browser

Interventional × Urinary Bladder Neoplasms × Cystoscopy × Clear all

NCT07061964 2026-04-22

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

Phase 2 Recruiting

Urinary Bladder Neoplasms

NCT03775265 2026-04-13

Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer

Phase 3 Active not recruiting

Urinary Bladder Neoplasms

NCT04164082 2026-04-13

Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer

Phase 2 Active not recruiting

Urinary Bladder Neoplasms

NCT07000084 2026-04-07

GAIN-BCG

Phase 3 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT06704191 2026-03-30

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

Phase 1/2 Recruiting

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03258593 2026-03-17

Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)

Phase 1 Completed

15 enrolled 21 charts

Urinary Bladder Neoplasms, Carcinoma in Situ

NCT07180212 2026-03-17

Guiding Value of Urinary Tumor DNA Testing in Cystoscopy for High-Risk/Very High-Risk Non-Muscle-Invasive Bladder Cancer

Phase NA Recruiting

Urinary Bladder Neoplasms

NCT06470282 2026-02-18

Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer

Phase 1/2 Recruiting

Urinary Bladder Neoplasms

NCT04216290 2025-11-12

A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE Trial

Phase 2 Active not recruiting

Urinary Bladder Neoplasms

NCT05564416 2025-10-21

Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial

Phase 2 Withdrawn

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT06944314 2025-04-27

Physicians' Perception About Patient Pain in Flexible Cystoscopy With Local Anesthesia

Phase NA Enrolling by invitation

Anxiety Disorders, Urinary Bladder Neoplasms, Hematuria, Pain

NCT06422312 2025-04-04

A Study Comparing a Disposable Flexible Cystoscope With Reusable Scopes in Adult Patients.

Phase NA Withdrawn

Urinary Bladder Calculi, Urinary Bladder Neck Obstruction, Urinary Bladder Neoplasms, Kidney Diseases, Nephrolithiasis

NCT02901548 2022-07-29

Phase 2 Durvalumab (Medi4736) for Bacillus Calmette-Guérin (BCG) Refactory Urothelial Carcinoma in Situ of the Bladder

Phase 2 Terminated

17 enrolled 9 charts

Urinary Bladder Diseases, Urinary Bladder Neoplasms, Carcinoma in Situ

NCT05362539 2022-05-05

Novel Urine-Based DNA Methylation Biomarkers for Urothelial Bladder Carcinoma Detection in Patients With Hematuria

Phase NA Completed

Urinary Bladder Neoplasms, Hematuria

NCT02700464 2021-05-04

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

Phase NA Completed

Urinary Bladder Neoplasms

NCT03831321 2019-02-05

The Effect of Preemptive Analgesia On The Comfort Of Patient and Doctor, in Cystoscopy

Phase 4 Unknown

Urinary Bladder Neoplasms, Hematuria, Pain, Prostatic Hyperplasia, Lower Urinary Tract Symptoms

NCT02145390 2018-08-28

Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy

Phase NA Terminated

1 enrolled 5 charts

Urinary Bladder Neoplasms

NCT00556621 2015-07-30

GEMCIRAV

Phase 1/2 Completed

Urinary Bladder Neoplasms

NCT00052637 2013-10-23

Cystoscopy and Hexyl 5-Aminolevulinate in Detecting Carcinoma In Situ in Patients With Bladder Cancer

Phase 3 Completed

Urinary Bladder Neoplasms